The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry, listed on the German MDAX and TecDAX stock markets. In fiscal 2020, the company recorded sales of €2.34 billion, growing by around 30%. Their ambition is to simplify progress in biopharmaceutical research and production. They support their customers with innovative technologies…More that make the development and manufacture of innovative therapeutics faster and more efficient. So that more people have access to better medicine. Nearly 11,000 employees at over 60 production and sales locations worldwide are committed to this vision.